חוב לטווח קצר להון polyrizon-biotech.com (PLRZ)

Polyrizon Ltd (PLRZ) is developing unique protective nasal gels, which guarantees the brand significant pricing power. Demand for such preventive measures is rising, ensuring an expanding customer base during the commercial launch period. The company's high scientific potential positions it to claim leadership in precision pharmacy. This price chart reflects the asset's market trend at the value of 0.00, visualizing the dynamics of this business.

Investors use this ratio to assess insolvency risk by calculating the proportion of short-term liabilities relative to equity. Analyzing the current short-term debt to equity value allows for the determination of the balance between debt financing and asset stability, which is critically important for Polyrizon Ltd (PLRZ) as it completes costly preclinical trials and prepares regulatory documentation for nasal barriers.